BRIEF published on 04/10/2025 at 17:40, 1 year 5 months ago FamiCord AG Surpasses 2024 Earnings Expectations EBITDA Annual Report 2024 Earnings Cell Banking FamiCord AG
PRESS RELEASE published on 04/10/2025 at 17:35, 1 year 5 months ago EQS-Adhoc: FamiCord AG significantly exceeds annual earnings guidance for 2024 on the basis of preliminary figures FamiCord AG surpasses 2024 earnings guidance with EUR 82.2 million revenue and EUR 8.8 million EBITDA based on preliminary figures EBITDA Revenue Preliminary Figures FamiCord AG 2024 Earnings Guidance
BRIEF published on 02/06/2025 at 07:35, 1 year 7 months ago Vita 34 AG Rebrands as FamiCord AG to Strengthen International Presence Rebranding Investor Relations International Growth FamiCord AG Stem Cell Banking
PRESS RELEASE published on 02/06/2025 at 07:30, 1 year 7 months ago Vita 34 AG strengthens its international brand presence by change of name to FamiCord AG Vita 34 AG rebrands to FamiCord AG to enhance international brand presence and facilitate further growth. Company maintains Vita 34 brand in DACH region Rebranding International Growth Vita 34 AG Cell Bank FamiCord AG
BRIEF published on 11/22/2024 at 07:05, 1 year 10 months ago Vita 34 Reports Revenue Growth and Cash Increase in Q3 2024 Revenue Growth Cash Flow Profitability Market Expansion Cell Banking
PRESS RELEASE published on 11/22/2024 at 07:00, 1 year 10 months ago Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024 Vita 34 AG reports revenue growth of 6.3% to EUR 60.3 million, EBITDA up 77.5% in Q3 2024. Positive cash flow and strong performance despite market challenges EBITDA Revenue Growth Market Challenges Cash Flow Vita 34 AG
BRIEF published on 08/30/2024 at 07:05, 2 years 1 month ago Vita 34 AG Sustains Growth in H1 2024, Strongly Boosts Operating Cash Flow Revenue Growth Operating Cash Flow Vita 34 AG EBITDA Increase H1 2024 Results
PRESS RELEASE published on 08/30/2024 at 07:00, 2 years 1 month ago Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow Vita 34 AG reports positive first half of 2024 with revenue growth and increased operating cash flow. EBITDA up by 76.4%. Full-year outlook confirmed EBITDA Revenue Growth Operating Cash Flow Vita 34 AG First Half Results
BRIEF published on 08/09/2024 at 17:09, 2 years 1 month ago Subsidiaries of Vita 34 Reach Agreement with US Licensor Vita 34 FamiCordTx PBKM CAR-T Technology Biotechnology Agreement
PRESS RELEASE published on 08/09/2024 at 17:04, 2 years 1 month ago EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG subsidiaries reach agreement with US licensor on CAR-T technology, settling previous lawsuit and securing new know-how licensing agreement Vita 34 AG Agreement Subsidiaries CAR-T Technology US Licensor
Published on 10/03/2026 at 02:35, 1 day 22 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 11 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 12 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 12 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 19 hours 19 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 20 hours 9 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 9 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 2 days 1 hour ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 2 days 5 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 7 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 3 days 6 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 3 days 6 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 3 days 7 hours ago Covivio - Information on total number of voting rights and share capital
